In four to eight weeks will likely know if bryostatin is the treatment for Alzheimer's that we hope it is. I'm not sure there's another company out there that will know with the same degree of certainty in the next month or two. That's the advantage we have as shareholders right now. Hopeful anticipation based on dr. Alkon's decades of experience. Jmho